CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 
 

ORMP's Net Income Growth by Quarter and Year

Oramed Pharmaceuticals Inc 's Net Income results by quarter and year




ORMP Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter August - 2.28 2.93 7.97
III Quarter May 2.28 4.07 4.35 1.97
II Quarter February 3.69 3.70 2.92 3.18
I Quarter November 2.54 4.30 2.53 -2.64
FY   8.51 14.35 12.73 10.48



ORMP Net Income third quarter 2020 Y/Y Growth Comment
Oramed Pharmaceuticals Inc reported fall in Net Income in the third quarter by -43.88% to $ 2.28 millions, from the same quarter in 2019.
The drop in the third quarter Oramed Pharmaceuticals Inc 's Net Income compares unfavorably to the Company's average Net Income growth of 1.94%.

According to the results reported in the third quarter, Oramed Pharmaceuticals Inc achieved the best Net Income growth in Major Pharmaceutical Preparations industry. While Oramed Pharmaceuticals Inc ' s Net Income drop of -43.88% ranks overall at the positon no. 37 in the third quarter.




ORMP Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter August - -22.18 % -63.24 % 67.44 %
III Quarter May -43.88 % -6.44 % 120.81 % -1.5 %
II Quarter February -0.27 % 26.71 % -8.18 % 74.73 %
I Quarter November -40.93 % 69.96 % - -
FY   - 12.73 % 21.47 % -4.47 %

Financial Statements
Oramed Pharmaceuticals Inc 's third quarter 2020 Net Income $ 2.28 millions ORMP's Income Statement
Oramed Pharmaceuticals Inc 's third quarter 2019 Net Income $ 4.07 millions Quarterly ORMP's Income Statement
New: More ORMP's historic Net Income Growth >>


ORMP Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter August - -43.98 % -32.64 % 304.57 %
III Quarter May -38.1 % 10 % 48.97 % -38.05 %
II Quarter February 45.28 % -13.95 % 15.42 % -
I Quarter November 11.4 % 46.76 % -68.26 % -
FY (Year on Year)   - 12.73 % 21.47 % -4.47 %




Net Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #37

Net Income Y/Y Growth Statistics
High Average Low
49.3 % 1.94 % -28.38 %
(Nov 30 2017)   (Aug 31 2018)
Net Income third quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #1
Healthcare Sector #3
Overall #37
Net Income Y/Y Growth Statistics
High Average Low
49.3 % 1.94 % -28.38 %
(Nov 30 2017)   (Aug 31 2018)

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Oramed Pharmaceuticals Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
305.5 % 12.07 % -100 %
(Aug 31 2017)  


ORMP's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2020 Oramed Pharmaceuticals Inc reported fall in Net Income from the second quarter by -38.1% to $ 2.28 millions, from $ 3.69 millions released in the previous reporting period.

Some cyclical circumstance which normally energize III. Quarter 2020 results, have not recover the III. Quarter for the Oramed Pharmaceuticals Inc , Riccardo Agnelli, an industry observer located in Milan said, he mentioned some pessimism for the Oramed Pharmaceuticals Inc 's outlook and mentioned that average quarter on quarter Net Income growth is at 12.07% for the Major Pharmaceutical Preparations's company.

Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Net Income quarter on quarter growth. While Oramed Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is 557.


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #43
Overall #557
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #10
Healthcare Sector #43
Overall #557
Net Income Q/Q Growth Statistics
High Average Low
305.5 % 12.07 % -100 %
(Aug 31 2017)  


ORMP's III. Quarter Q/Q Net Income Comment
In the III. Quarter 2020 Oramed Pharmaceuticals Inc realized fall in Net Income from the previous quarter by -38.1% to $ 2.28 millions, from $ 3.69 millions released in the previous reporting period.

Even cyclical circumstance were not able to salvage the III. Quarter for the Oramed Pharmaceuticals Inc , Riccardo Agnelli, an industry observer located in Milan pointed out, he detected new challenges ahead for ORMP and continued that average sequential Net Income growth is at 12.07% for ORMP.

Within Major Pharmaceutical Preparations industry 9 other companies have achieved higher Net Income quarter on quarter growth. While Oramed Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is 557.


Oramed Pharmaceuticals Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(May 31 2020)
12 Months Ending
(Feb 29 2020)
12 Months Ending
(Nov 30 2019)
12 Months Ending
(Aug 31 2019)
12 Months Ending
(May 31 2019)
Cumulative Net Income 12 Months Ending $ 10.80 $ 12.58 $ 12.60 $ 14.36 $ 15.00
Y / Y Net Income Growth (TTM) -28.04 % -17.67 % -13.12 % 12.79 % -15.58 %
Year on Year Net Income Growth Overall Ranking # 38 # 39 # 31 # 811 # 28
Seqeuential Net Income Change (TTM) -14.21 % -0.1 % -12.25 % -4.31 % -1.85 %
Seq. Net Income Growth (TTM) Overall Ranking # 37 # 273 # 36 # 1310 # 24




Cumulative Net Income growth Comment
Oramed Pharmaceuticals Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -28.04% year on year, at May 31 2020 compare to the -17.67% decrease at Feb 29 2020. If the Oramed Pharmaceuticals Inc 's fiscal year would end at May 31 2020, annual Net Income would be $11 millions.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 38, from total ranking in previous quarter at 39.

Net Income TTM Q/Q Growth Statistics
High Average Low
49.3 %
1.94 %
-28.38 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 3
Overall # 38

Net Income TTM Y/Y Growth Statistics
High Average Low
163.51 %
33.66 %
-28.04 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 37
Cumulative Net Income growth Comment
Oramed Pharmaceuticals Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -28.04% year on year, at May 31 2020 compare to the -17.67% decrease at Feb 29 2020. If the Oramed Pharmaceuticals Inc 's fiscal year would end at May 31 2020, annual Net Income would be $11 millions.

Among companies within the Healthcare sector 2 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 38, from total ranking in previous quarter at 39.

Net Income TTM Q/Q Growth Statistics
High Average Low
49.3 %
1.94 %
-28.38 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 1
Healthcare Sector # 3
Overall # 38

Net Income TTM Y/Y Growth Statistics
High Average Low
163.51 %
33.66 %
-28.04 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 3
S&P 500 # 37




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ORMP's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ORMP's Competitors
Net Income Growth for Oramed Pharmaceuticals Inc 's Suppliers
Net Income Growth for ORMP's Customers

You may also want to know
ORMP's Annual Growth Rates ORMP's Profitability Ratios ORMP's Asset Turnover Ratio ORMP's Dividend Growth
ORMP's Roe ORMP's Valuation Ratios ORMP's Financial Strength Ratios ORMP's Dividend Payout Ratio
ORMP's Roa ORMP's Inventory Turnover Ratio ORMP's Growth Rates ORMP's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending May 31 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending May 31 2020
Oramed Pharmaceuticals Inc -43.91 %$ -43.910 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

KOP's Profile

Stock Price

KOP's Financials

Business Description

Fundamentals

Charts & Quotes

KOP's News

Suppliers

KOP's Competitors

Customers & Markets

Economic Indicators

KOP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071